Clal Biotechnology (Israel) Widgets and Gadgets
| CBI Stock | 44.60 3.50 8.52% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- CBI Clal Biotechnology Industries
- CBI 44.6 3.5
- Low 41.9
- High 46.2
- Alpha 0.23
- Beta -0.81
- Return On Equity -0.45
- Return On Asset -0.12
- Profit Margin (1.14) %
- Operating Margin (0.86) %
- Current Valuation 89.12 M
- Shares Outstanding 156.85 M
- Shares Owned By Insiders 64.58 %
- Price To Earning (218.28) X
- Price To Book 0.68 X
- Price To Sales 2.79 X
- Revenue 76.96 M
- Gross Profit 10.72 M
- EBITDA (98.18 M)
- Net Income (89.58 M)
- Cash And Equivalents 94.71 M
- Cash Per Share 0.59 X
- Total Debt 52.28 M
- Debt To Equity 6.30 %
- Current Ratio 3.67 X
- Book Value Per Share 0.84 X
- Cash Flow From Operations (41.33 M)
- Earnings Per Share (0.57) X
- Target Price 30.0
- Number Of Employees 21
- Beta 0.9
- Market Capitalization 122.65 M
- Total Asset 444.92 M
- Retained Earnings (823 M)
- Working Capital 193 M
- Current Asset 254 M
- Current Liabilities 61 M
- Z Score -0.2
- Annual Yield 0.18 %
- Net Asset 444.92 M
- Accumulation Distribution 0.0931
- Daily Balance Of Power 0.814
- Rate Of Daily Change 1.09
- Day Median Price 44.05
- Day Typical Price 44.23
- Market Facilitation Index 4.3
- Price Action Indicator 2.3
- Period Momentum Indicator 3.5
- Relative Strength Index 54.12
Market Snapshot Widget Example
DAX Index Germany | 17,770 0.02 | |
Taiwan Weighted Taiwan | 20,213 1.56 | |
PSI 20 Stock Portugal | 6,234 0.16 | |
CROBEX Croatia | 2,813 0.65 | |
Budapest SE Hungary | 66,115 1.05 | |
IDX 30 Jakarta Indonesia | 470.93 0.54 | |
ISEQ 20 Price Ireland | 1,620 1.32 | |
NYSE Comp USA | 17,403 0.06 | |
Tel Aviv 35 Israel | 1,888 1.03 | |
Coreshares Index Tracker South Afric | 1,021 0.29 | |
IPC MEXICO Mexico | 55,416 0.68 | |
KL Technology Malaysia | 63.80 1.16 | |
IBEX 35 Index Spain | 10,634 1.02 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,508 0.30 | |
SPASX Dividend Opportunities Australia | 1,661 0.63 | |
HNX 30 Vietnam | 496.19 0.26 | |
Bucharest BET-NG Romania | 1,201 0.59 | |
AMS Small Cap Netherlands | 1,217 1.03 | |
Oslo Exchange Mutual Norway | 1,296 0.43 | |
BEL Small Belgium | 8,960 1.74 | |
RTSI Index Russia | 1,154 0.16 | |
Basic Materials Brazil | 5,868 0.16 | |
Swiss Leader Price Switzerland | 1,839 0.20 | |
Fondo Mutuo ETF Chile | 1,415 0.56 | |
Athens General Comp Greece | 1,365 0.60 | |
Stock Exchange Of Thailand | 1,367 0.81 | |
PX Prague Stock Czech Repub | 1,547 0.68 | |
THE PHILIPPINE STOCK Philippines | 6,450 0.70 | |
WIG 30 Poland | 3,014 1.46 | |
BIST Electricity Turkey | 579.32 0.19 |
Investing Ideas
In addition to having Clal Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Clal Biotechnology
Compare Clal Biotechnology To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clal Biotechnology Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Clal Stock analysis
When running Clal Biotechnology's price analysis, check to measure Clal Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clal Biotechnology is operating at the current time. Most of Clal Biotechnology's value examination focuses on studying past and present price action to predict the probability of Clal Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clal Biotechnology's price. Additionally, you may evaluate how the addition of Clal Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |